HIGHLIGHTS
- who: Bone-Targeted Agents et al. from the Department of Oncology and Metabolism, University of Sheffield, Sheffield , RX, UK have published the Article: Simple Summary: metastases are common in cancer patients and the role of in of have been evaluated in multiple clinical trials over the past years, in the Journal: Cancers 2022, 14, 3640. of /2022/
- what: Very recently, the 4 of 9 long-term follow-up results from this study have been presented and suggest, in this population of relatively good prognosis postmenopausal women receiving aromatase inhibitors, that adjuvant denosumab may be influencing . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.